Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Tribute to Caren Hall.

Journal of the Pediatric Infectious Diseases Society

Englund J, Karron R, Dennehy P, Kimberlin D.
PMID: 26619456
J Pediatric Infect Dis Soc. 2013 Jun;2(2):93-6. doi: 10.1093/jpids/pit006. Epub 2013 Mar 26.

No abstract available.

Cite
Englund J, Karron R, Dennehy P, et al. Tribute to Caren Hall. J Pediatric Infect Dis Soc. 2013;2(2):93-6doi: 10.1093/jpids/pit006.
Englund, J., Karron, R., Dennehy, P., & Kimberlin, D. (2013). Tribute to Caren Hall. Journal of the Pediatric Infectious Diseases Society, 2(2), 93-6. https://doi.org/10.1093/jpids/pit006
Englund, Janet, et al. "Tribute to Caren Hall." Journal of the Pediatric Infectious Diseases Society vol. 2,2 (2013): 93-6. doi: https://doi.org/10.1093/jpids/pit006
Englund J, Karron R, Dennehy P, Kimberlin D. Tribute to Caren Hall. J Pediatric Infect Dis Soc. 2013 Jun;2(2):93-6. doi: 10.1093/jpids/pit006. Epub 2013 Mar 26. PMID: 26619456.
Copy Download .nbib Format: NLM
Update From the Advisory Committee on Immunization Practices.

Journal of the Pediatric Infectious Diseases Society

Schlaudecker EP, Englund JA, Kimberlin DW.
PMID: 26619493
J Pediatric Infect Dis Soc. 2013 Dec;2(4):309-11. doi: 10.1093/jpids/pit042. Epub 2013 Aug 08.

No abstract available.

Cite
Schlaudecker EP, Englund JA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2013;2(4):309-11doi: 10.1093/jpids/pit042.
Schlaudecker, E. P., Englund, J. A., & Kimberlin, D. W. (2013). Update From the Advisory Committee on Immunization Practices. Journal of the Pediatric Infectious Diseases Society, 2(4), 309-11. https://doi.org/10.1093/jpids/pit042
Schlaudecker, Elizabeth P, et al. "Update From the Advisory Committee on Immunization Practices." Journal of the Pediatric Infectious Diseases Society vol. 2,4 (2013): 309-11. doi: https://doi.org/10.1093/jpids/pit042
Schlaudecker EP, Englund JA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2013 Dec;2(4):309-11. doi: 10.1093/jpids/pit042. Epub 2013 Aug 08. PMID: 26619493.
Copy Download .nbib Format: NLM
Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

McKelvey RP, Hatton RC, Kimberlin CA.
PMID: 20479106
Am J Health Syst Pharm. 2010 May 15;67(10):830-6. doi: 10.2146/ajhp090090.

PURPOSE: The publication rates and characteristics of residency projects presented at the Southeastern Residency Conference (SERC) in 1981, 1991, and 2001 are described.METHODS: SERC abstracts from 1981, 1991, and 2001 were searched in MEDLINE and International Pharmaceutical Abstracts with...

Cite
McKelvey RP, Hatton RC, Kimberlin CA. Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001. Am J Health Syst Pharm. 2010;67(10):830-6doi: 10.2146/ajhp090090.
McKelvey, R. P., Hatton, R. C., & Kimberlin, C. A. (2010). Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 67(10), 830-6. https://doi.org/10.2146/ajhp090090
McKelvey, Russell P, et al. "Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 67,10 (2010): 830-6. doi: https://doi.org/10.2146/ajhp090090
McKelvey RP, Hatton RC, Kimberlin CA. Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001. Am J Health Syst Pharm. 2010 May 15;67(10):830-6. doi: 10.2146/ajhp090090. PMID: 20479106.
Copy Download .nbib Format: NLM
Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana.

Veterinary medicine international

Miller DS, Weiser GC, Aune K, Roeder B, Atkinson M, Anderson N, Roffe TJ, Keating KA, Chapman PL, Kimberling C, Rhyan J, Clarke PR.
PMID: 22195293
Vet Med Int. 2011;2011:162520. doi: 10.4061/2011/162520. Epub 2011 Nov 16.

Transmission of infectious agents from livestock reservoirs has been hypothesized to cause respiratory disease outbreaks in bighorn sheep (Ovis canadensis), and land management policies intended to limit this transmission have proven controversial. This cross-sectional study compares the infectious agents...

Cite
Miller DS, Weiser GC, Aune K, et al. Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana. Vet Med Int. 2011;2011:162520doi: 10.4061/2011/162520.
Miller, D. S., Weiser, G. C., Aune, K., Roeder, B., Atkinson, M., Anderson, N., Roffe, T. J., Keating, K. A., Chapman, P. L., Kimberling, C., Rhyan, J., & Clarke, P. R. (2011). Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana. Veterinary medicine international, 2011162520. https://doi.org/10.4061/2011/162520
Miller, David S, et al. "Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana." Veterinary medicine international vol. 2011 (2011): 162520. doi: https://doi.org/10.4061/2011/162520
Miller DS, Weiser GC, Aune K, Roeder B, Atkinson M, Anderson N, Roffe TJ, Keating KA, Chapman PL, Kimberling C, Rhyan J, Clarke PR. Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana. Vet Med Int. 2011;2011:162520. doi: 10.4061/2011/162520. Epub 2011 Nov 16. PMID: 22195293; PMCID: PMC3236376.
Copy Download .nbib Format: NLM
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Benner KW, Worthington MA, Kimberlin DW, Hill K, Buckley K, Tofil NM.
PMID: 23055895
J Pediatr Pharmacol Ther. 2009 Apr;14(2):86-93. doi: 10.5863/1551-6776-14.2.86.

OBJECTIVES: Appropriate antimicrobial dosing maximizes therapeutic benefit while minimizing development of antimicrobial resistance. Common pediatric references recommend vancomycin dosing of 40 mg/kg/day divided every 6 to 8 hours for non-central nervous system infections, while some clinicians report utilizing higher...

Cite
Benner KW, Worthington MA, Kimberlin DW, et al. Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. J Pediatr Pharmacol Ther. 2009;14(2):86-93doi: 10.5863/1551-6776-14.2.86.
Benner, K. W., Worthington, M. A., Kimberlin, D. W., Hill, K., Buckley, K., & Tofil, N. M. (2009). Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 14(2), 86-93. https://doi.org/10.5863/1551-6776-14.2.86
Benner, Kim W, et al. "Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 14,2 (2009): 86-93. doi: https://doi.org/10.5863/1551-6776-14.2.86
Benner KW, Worthington MA, Kimberlin DW, Hill K, Buckley K, Tofil NM. Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. J Pediatr Pharmacol Ther. 2009 Apr;14(2):86-93. doi: 10.5863/1551-6776-14.2.86. PMID: 23055895; PMCID: PMC3461982.
Copy Download .nbib Format: NLM
Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.

Antiviral research

Ross SA, Kimberlin D.
PMID: 33964331
Antiviral Res. 2021 Jul;191:105083. doi: 10.1016/j.antiviral.2021.105083. Epub 2021 May 05.

Congenital cytomegalovirus (cCMV) infection is a leading cause of hearing loss and neurological disabilities in children worldwide. Although a minority of infants with cCMV will have symptoms at a birth, these children are at high risk of long-term sequelae....

Cite
Ross SA, Kimberlin D. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral Res. 2021;191:105083doi: 10.1016/j.antiviral.2021.105083.
Ross, S. A., & Kimberlin, D. (2021). Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral research, 191105083. https://doi.org/10.1016/j.antiviral.2021.105083
Ross, Shannon A, and Kimberlin, David. "Clinical outcome and the role of antivirals in congenital cytomegalovirus infection." Antiviral research vol. 191 (2021): 105083. doi: https://doi.org/10.1016/j.antiviral.2021.105083
Ross SA, Kimberlin D. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral Res. 2021 Jul;191:105083. doi: 10.1016/j.antiviral.2021.105083. Epub 2021 May 05. PMID: 33964331.
Copy Download .nbib Format: NLM
Update From the Advisory Committee on Immunization Practices.

Journal of the Pediatric Infectious Diseases Society

James SH, Sawyer MH, Kimberlin DW.
PMID: 26625361
J Pediatric Infect Dis Soc. 2014 Jun;3(2):94-7. doi: 10.1093/jpids/piu026. Epub 2014 Apr 10.

No abstract available.

Cite
James SH, Sawyer MH, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2014;3(2):94-7doi: 10.1093/jpids/piu026.
James, S. H., Sawyer, M. H., & Kimberlin, D. W. (2014). Update From the Advisory Committee on Immunization Practices. Journal of the Pediatric Infectious Diseases Society, 3(2), 94-7. https://doi.org/10.1093/jpids/piu026
James, Scott H, et al. "Update From the Advisory Committee on Immunization Practices." Journal of the Pediatric Infectious Diseases Society vol. 3,2 (2014): 94-7. doi: https://doi.org/10.1093/jpids/piu026
James SH, Sawyer MH, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2014 Jun;3(2):94-7. doi: 10.1093/jpids/piu026. Epub 2014 Apr 10. PMID: 26625361.
Copy Download .nbib Format: NLM
Update From the Advisory Committee on Immunization Practices.

Journal of the Pediatric Infectious Diseases Society

James SH, Englund JA, Kimberlin DW.
PMID: 26625448
J Pediatric Infect Dis Soc. 2014 Dec;3(4):282-5. doi: 10.1093/jpids/piu088. Epub 2014 Sep 08.

No abstract available.

Cite
James SH, Englund JA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2014;3(4):282-5doi: 10.1093/jpids/piu088.
James, S. H., Englund, J. A., & Kimberlin, D. W. (2014). Update From the Advisory Committee on Immunization Practices. Journal of the Pediatric Infectious Diseases Society, 3(4), 282-5. https://doi.org/10.1093/jpids/piu088
James, Scott H, et al. "Update From the Advisory Committee on Immunization Practices." Journal of the Pediatric Infectious Diseases Society vol. 3,4 (2014): 282-5. doi: https://doi.org/10.1093/jpids/piu088
James SH, Englund JA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2014 Dec;3(4):282-5. doi: 10.1093/jpids/piu088. Epub 2014 Sep 08. PMID: 26625448.
Copy Download .nbib Format: NLM
Update From the Advisory Committee on Immunization Practices.

Journal of the Pediatric Infectious Diseases Society

O Leary ST, Maldonado YA, Kimberlin DW.
PMID: 33180938
J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):645-649. doi: 10.1093/jpids/piaa144.

The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, normally meets 3 times per year to develop recommendations for vaccine use in the United States. Because of the severe acute respiratory syndrome Coronavirus...

Cite
O Leary ST, Maldonado YA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2020;9(6):645-649doi: 10.1093/jpids/piaa144.
O Leary, S. T., Maldonado, Y. A., & Kimberlin, D. W. (2020). Update From the Advisory Committee on Immunization Practices. Journal of the Pediatric Infectious Diseases Society, 9(6), 645-649. https://doi.org/10.1093/jpids/piaa144
O Leary, Sean T, et al. "Update From the Advisory Committee on Immunization Practices." Journal of the Pediatric Infectious Diseases Society vol. 9,6 (2020): 645-649. doi: https://doi.org/10.1093/jpids/piaa144
O Leary ST, Maldonado YA, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):645-649. doi: 10.1093/jpids/piaa144. PMID: 33180938; PMCID: PMC7717312.
Copy Download .nbib Format: NLM
Disability in cultural competency pharmacy education.

American journal of pharmaceutical education

Smith WT, Roth JJ, Okoro O, Kimberlin C, Odedina FT.
PMID: 21519416
Am J Pharm Educ. 2011 Mar 10;75(2):26. doi: 10.5688/ajpe75226.

Improving health care providers' knowledge and ability to provide culturally competent care can limit the health disparities experienced by disadvantaged populations. As racial and ethnic cultures dominate cultural competency topics in education, alternative cultures such as disability have consistently...

Cite
Smith WT, Roth JJ, Okoro O, et al. Disability in cultural competency pharmacy education. Am J Pharm Educ. 2011;75(2):26doi: 10.5688/ajpe75226.
Smith, W. T., Roth, J. J., Okoro, O., Kimberlin, C., & Odedina, F. T. (2011). Disability in cultural competency pharmacy education. American journal of pharmaceutical education, 75(2), 26. https://doi.org/10.5688/ajpe75226
Smith, W Thomas, et al. "Disability in cultural competency pharmacy education." American journal of pharmaceutical education vol. 75,2 (2011): 26. doi: https://doi.org/10.5688/ajpe75226
Smith WT, Roth JJ, Okoro O, Kimberlin C, Odedina FT. Disability in cultural competency pharmacy education. Am J Pharm Educ. 2011 Mar 10;75(2):26. doi: 10.5688/ajpe75226. PMID: 21519416; PMCID: PMC3073100.
Copy Download .nbib Format: NLM
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.

European journal of haematology

Bouvier A, Hamel JF, Delaunay J, Delabesse E, Dumas PY, Ledoux MP, Peterlin P, Luquet I, Roth Guepin G, Bulabois CE, Gallego Hernanz MP, Guillerm G, Guieze R, Hicheri Y, Simand C, Himberlin C, Hunault-Berger M, Bernard M, Jourdan E, Caillot D, Dorvaux V, Tavernier E, Daguindau E, Banos A, Ojeda-Uribe M, Gyan E, Alexis M, Marolleau JP, Turlure P, Bouscary D, Humbrecht C, Zerazhi H, Béné MC, Pigneux A, Carre M, Ifrah N, Blanchet O, Vey N, Récher C, Cornillet-Lefèbvre P.
PMID: 33765335
Eur J Haematol. 2021 Jul;107(1):111-121. doi: 10.1111/ejh.13626. Epub 2021 Apr 18.

In this randomized phase 3 study, the FILO group tested whether the addition of 6 mg/m

Cite
Bouvier A, Hamel JF, Delaunay J, et al. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial. Eur J Haematol. 2021;107(1):111-121doi: 10.1111/ejh.13626.
Bouvier, A., Hamel, J. F., Delaunay, J., Delabesse, E., Dumas, P. Y., Ledoux, M. P., Peterlin, P., Luquet, I., Roth Guepin, G., Bulabois, C. E., Gallego Hernanz, M. P., Guillerm, G., Guieze, R., Hicheri, Y., Simand, C., Himberlin, C., Hunault-Berger, M., Bernard, M., Jourdan, E., Caillot, D., Dorvaux, V., Tavernier, E., Daguindau, E., Banos, A., Ojeda-Uribe, M., Gyan, E., Alexis, M., Marolleau, J. P., Turlure, P., Bouscary, D., Humbrecht, C., Zerazhi, H., Béné, M. C., Pigneux, A., Carre, M., Ifrah, N., Blanchet, O., Vey, N., Récher, C., Cornillet-Lefèbvre, P. (2021). Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial. European journal of haematology, 107(1), 111-121. https://doi.org/10.1111/ejh.13626
Bouvier, Anne, et al. "Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial." European journal of haematology vol. 107,1 (2021): 111-121. doi: https://doi.org/10.1111/ejh.13626
Bouvier A, Hamel JF, Delaunay J, Delabesse E, Dumas PY, Ledoux MP, Peterlin P, Luquet I, Roth Guepin G, Bulabois CE, Gallego Hernanz MP, Guillerm G, Guieze R, Hicheri Y, Simand C, Himberlin C, Hunault-Berger M, Bernard M, Jourdan E, Caillot D, Dorvaux V, Tavernier E, Daguindau E, Banos A, Ojeda-Uribe M, Gyan E, Alexis M, Marolleau JP, Turlure P, Bouscary D, Humbrecht C, Zerazhi H, Béné MC, Pigneux A, Carre M, Ifrah N, Blanchet O, Vey N, Récher C, Cornillet-Lefèbvre P. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial. Eur J Haematol. 2021 Jul;107(1):111-121. doi: 10.1111/ejh.13626. Epub 2021 Apr 18. PMID: 33765335.
Copy Download .nbib Format: NLM
Acyclovir Dosing in the Neonatal Period and Beyond.

Journal of the Pediatric Infectious Diseases Society

Kimberlin DW.
PMID: 26619466
J Pediatric Infect Dis Soc. 2013 Jun;2(2):179-82. doi: 10.1093/jpids/pis138. Epub 2013 Feb 11.

No abstract available.

Cite
Kimberlin DW. Acyclovir Dosing in the Neonatal Period and Beyond. J Pediatric Infect Dis Soc. 2013;2(2):179-82doi: 10.1093/jpids/pis138.
Kimberlin, D. W. (2013). Acyclovir Dosing in the Neonatal Period and Beyond. Journal of the Pediatric Infectious Diseases Society, 2(2), 179-82. https://doi.org/10.1093/jpids/pis138
Kimberlin, David W. "Acyclovir Dosing in the Neonatal Period and Beyond." Journal of the Pediatric Infectious Diseases Society vol. 2,2 (2013): 179-82. doi: https://doi.org/10.1093/jpids/pis138
Kimberlin DW. Acyclovir Dosing in the Neonatal Period and Beyond. J Pediatric Infect Dis Soc. 2013 Jun;2(2):179-82. doi: 10.1093/jpids/pis138. Epub 2013 Feb 11. PMID: 26619466.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries